Ultrastructure of mouse striated muscle fibers following pravastatin administration

被引:20
作者
Bergman, M
Salman, H
Djaldetti, M
Alexandrova, S
Punsky, I
Bessler, H
机构
[1] Rabin Med Ctr, Lab Immunol & Hematol Res, Petah Tiqwa, Israel
[2] Rabin Med Ctr, Dept Med C, Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1023/A:1027367022415
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To examine the effect of pravastatin administration on striated muscle ultrastructure, 10 BalbC mice were given pravastatin 40 mg/kg/day for 3 weeks. At the end of the study, blood was withdrawn for evaluation of the serum creatine phospho-kinase (CPK) level and the muscles of the hind legs, as well as the heart and liver of the animals were examined with a light and transmission electron microscope. After treatment with pravastatin the results showed a 101% increase in serum CPK level in comparison to untreated controls. Hematoxillin-eosin stained tissues of pravastatin treated mice did not show any abnormal findings. While the ultrastructure of the heart and liver of the treated animals appeared normal, the muscle fibers showed a marked alterations of the mitochondria, which were increased in size compared to those of the controls. The cristae were heavily damaged and even completely destructed, giving the mitochondria appearance of empty vacuoles. The findings are in favor of a specificity of pravastatin for striated muscles.
引用
收藏
页码:417 / 420
页数:4
相关论文
共 20 条
[1]   Pravastatin and low-dose cyclosporine treatment prevent islet allograft rejection in mice [J].
Arita, S ;
Kasraie, A ;
Une, S ;
Ohtsuka, S ;
Atiya, A ;
Shevlin, L ;
Mullen, Y .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (02) :522-522
[2]  
DECOULX E, 1993, ANN CARDIOL ANGEIOL, V42, P267
[3]   Comparative toxicity of high doses of vastatins currently used by clinicians, in CD-1 male mice fed with a hypercholesterolemic diet [J].
Díaz-Zagoya, JC ;
Asenjo-Barrón, JC ;
Cárdenas-Vázquez, R ;
Martínez, F ;
Juárez-Oropeza, MA .
LIFE SCIENCES, 1999, 65 (09) :947-956
[4]   HMG CoA reductase inhibitor-induced myotoxicity: Pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture [J].
Flint, OP ;
Masters, BA ;
Gregg, RE ;
Durham, SK .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 145 (01) :99-110
[5]   LOVASTATIN DECREASES COENZYME-Q LEVELS IN HUMANS [J].
FOLKERS, K ;
LANGSJOEN, P ;
WILLIS, R ;
RICHARDSON, P ;
XIA, LJ ;
YE, CQ ;
TAMAGAWA, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :8931-8934
[6]   EFFECTS OF HMG-COA REDUCTASE INHIBITORS ON SKELETAL-MUSCLES OF RABBITS [J].
FUKAMI, M ;
MAEDA, N ;
FUKUSHIGE, J ;
KOGURE, Y ;
SHIMADA, Y ;
OGAWA, T ;
TSUJITA, Y .
RESEARCH IN EXPERIMENTAL MEDICINE, 1993, 193 (05) :263-273
[7]   DIFFERENTIAL SENSITIVITY OF C-2-C-12 STRIATED-MUSCLE CELLS TO LOVASTATIN AND PRAVASTATIN [J].
GADBUT, AP ;
CARUSO, AP ;
GALPER, JB .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (10) :2397-2402
[8]   DRUG-INDUCED MYOPATHIES [J].
LEQUINTREC, JS ;
LEQUINTREC, JL .
BAILLIERES CLINICAL RHEUMATOLOGY, 1991, 5 (01) :21-38
[9]   IN-VITRO MYOTOXICITY OF THE 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITORS, PRAVASTATIN, LOVASTATIN, AND SIMVASTATIN, USING NEONATAL RAT SKELETAL MYOCYTES [J].
MASTERS, BA ;
PALMOSKI, MJ ;
FLINT, OP ;
GREGG, RE ;
WANGIVERSON, D ;
DURHAM, SK .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 131 (01) :163-174
[10]  
MORTENSEN SA, 1997, MOL ASPECT MED, V18, P137